Insider · CIK 0001612084
John B Bode
Files at SGRP (SPAR Group, Inc.), ZVRA (ZEVRA THERAPEUTICS, INC.), NWTG (Newton Golf Company, Inc.). First filing Mar 21, 2025, latest Aug 20, 2025.
In brief
John B Bode files SEC Form 4 as director at ZVRA (ZEVRA THERAPEUTICS, INC.), and also at SGRP (SPAR Group, Inc.), NWTG (Newton Golf Company, Inc.). Since Mar 21, 2025, John B Bode has reported 2 open-market buys worth $125k and 0 open-market sells worth $0, the latest filed on Aug 20, 2025.
A track record needs three past buys with six months of prices behind them; John B Bode has 0, so none is measured yet.
The newest scored trade: bought $46k of ZVRA on Aug 19, 2025, filed Aug 20, 2025, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZVRA: ZEVRA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | ZVRAbuy ZEVRA THERAPEUTICS, INC. | $46k 5,000 shares | +13% | +37% from low-30% from high | |
| 30Weak | ZVRAbuy ZEVRA THERAPEUTICS, INC. | $80k 10,000 shares | +33% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 8, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | 10,516 0.02% of outstanding | $156k | Jul 8, 2026 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | SGRP SPAR Group, Inc. | AGrant or award Common Stock | +110,000 | - | - | 110,000 | 12 d ago |
| Mar 24, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock | +39,200 | $4.97 | $195k | 84,200 | Mar 26, 2026 |
| Mar 24, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock | +39,200 | $4.89 | $192k | 123,400 | Mar 26, 2026 |
| Mar 24, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Stock Option (right to buy)derivative | -39,200 | $0.00 | $0 | 19,600 | Mar 26, 2026 |
| Mar 24, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Stock Option (right to buy)derivative | -39,200 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Jan 30, 2026 | NWTG Newton Golf Company, Inc. | AGrant or award Common Stock | +18,549 | $0.00 | $0 | 18,549 | Feb 3, 2026 |
| Aug 19, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +5,000 | $9.17 | $46k | 45,000 | Aug 20, 2025 |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 30, 2025 |
| Mar 19, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +10,000 | $7.96 | $80k | 40,000 | Mar 21, 2025 |
Questions about John B Bode
Answered from the filings on this page, as of the latest one.
Is John B Bode buying or selling?
Not in the last 12 months. John B Bode's latest open-market trade on SEC Form 4 was bought $46k of ZVRA on Aug 19, 2025.
How did John B Bode's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John B Bode has 0.
Where does John B Bode file Form 4?
John B Bode has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.); SGRP (SPAR Group, Inc.); NWTG (Newton Golf Company, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.